JPRN-UMIN000008032招募中2 期
A phase II study of Bevacizumab plus Pemetrexed for previously treated Non Small Cell Lung Cancer with T790M mutation - A phase II study of Bevacizumab plus Pemetrexed for previously treated Non Small Cell Lung Cancer with T790M mutation
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of hemoptysis ( >= 2.5mL) 2) History of continuous hemosputum 3) Untreated Brain metastasis 4) Previously treated with Pemetrexed 5) Receiving a blood transfusion, hematopoietic factor, anticoagulant drug 2 weeks prior to enrollment 6)Patients with active severe infections 7) Patients with therapeutic anticoagulopathy (including Aspirin over 325mg/day) 8) Current or previous history of GI perforation 9) Patients with uncontrollable complications 10) Pregnancy, breast feeding and suspected pregnancy 11) Active concomitant malignancy 12)Inappropriate patients for this study judged by the physicians
研究者
相似试验
已完成
2 期
Phase II study of Bevacizumab + Pemetrexed in elderly patients with advanced non-squamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000010733Central Japan Lung Study Group37
已完成
2 期
Phase II study of Pemetrexed plus Bevacizumab (YCRG04) in exacerbation cases of Non-squamous Non-small cell lung cancer, previously treated with bevacizumab plus platinum-based chemotherapy.on-Squamous Non-Small Cell Lung CancerJPRN-UMIN000006721Yokohama City University Medical Center45
招募中
2 期
Phase II Study of Pemetrexed+Bevacizumab for previously untreated elderly patients with nonsquamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000008781Toho university medical center sakura hospital25
招募中
2 期
A Phase II study of Pemetrexed/Bevacizumab in patients ineligible for platinum-based chemotherapy with untreated Advanced Non-squamous non-small-cell lung cancer (ALCT003)on-squamous Non-small cell lung cancerJPRN-UMIN000010805Department of Respiratory Medicine Kyorin Univercity Hospital25
尚未招募
2 期
A phase II trial of pemetrexed/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.elderly patients with stage IIIB/IV non-small cell lung cancer except for squamous cell carcinomaJPRN-UMIN000008764Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School36